NEW YORK (GenomeWeb News) - Accuri Cytometers has netted $5 million in Series B financing from Baird Venture Partners and Arboretum Ventures, the company said today.
 
Accuri said it will use the money to fund further testing and to propel the full commercial launch of its C6 flow cytometer system.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.